Identification of a retinoic acid receptor alpha subtype specific agonist.
Teng
M
M
Department of Chemistry, Allergan Incorporated, Irvine, California 92713-9534, USA.
Duong
T T
TT
Klein
E S
ES
Pino
M E
ME
Chandraratna
R A
RA
D062365:Aminobenzoates / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D001565:Benzoates / Q000378:metabolism; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D017930:Genes, Reporter / Q000235:genetics; D015394:Molecular Structure; D011485:Protein Binding; D018168:Receptors, Retinoic Acid / Q000819:agonists* / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D000072482:Retinoic Acid Receptor alpha; D047488:Retinoid X Receptors; D012176:Retinoids / Q000378:metabolism; D013764:Tetrahydronaphthalenes / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D014157:Transcription Factors / Q000378:metabolism; D015533:Transcriptional Activation; D014162:Transfection
C100910:AGN 193835; C100911:AGN 193836; D062365:Aminobenzoates; D001565:Benzoates; D018168:Receptors, Retinoic Acid; D011993:Recombinant Fusion Proteins; D000072482:Retinoic Acid Receptor alpha; D047488:Retinoid X Receptors; D012176:Retinoids; D013764:Tetrahydronaphthalenes; D014157:Transcription Factors; C068073:Am 580